help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grad, J. M.
Right arrow Articles by Burnstein, K. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grad, J. M.
Right arrow Articles by Burnstein, K. L.
Molecular Endocrinology 13 (11): 1896-1911
Copyright © 1999 by The Endocrine Society

Multiple Androgen Response Elements and a Myc Consensus Site in the Androgen Receptor (AR) Coding Region Are Involved in Androgen-Mediated Up-Regulation of AR Messenger RNA

Jennifer M. Grad, Jia Le Dai1, Shu Wu2 and Kerry L. Burnstein

Department of Molecular and Cellular Pharmacology University of Miami School of Medicine Miami, Florida 33101

The androgen receptor (AR) gene is transcriptionally regulated by AR (autoregulation); however, the androgen response elements (AREs) required for this process have not been found in the AR promoter or in the 5'-flanking region. We previously showed that the AR cDNA contains AREs involved in AR mRNA autoregulation and that auto(up)regulation is reproduced in PC3 cells (a human prostate cancer cell line) expressing the human AR cDNA driven by a heterologous promoter. A 350-bp fragment of the AR cDNA contains the requisite AREs (ARE-1 and ARE-2) and, when linked upstream of a reporter gene, confers androgen inducibility in a cell-specific manner. Here we report that, although an AR cDNA harboring silent mutations of ARE-1 and ARE-2 produces a transcriptionally active AR, AR mRNA encoded by this mutant cDNA is not up-regulated in androgen-treated PC3 cells. Thus, ARE-1 and ARE-2 are essential for androgen-mediated up-regulation of AR mRNA in this model. Since ARE-1 and ARE-2 are located on separate exons (exons D and E) in the AR gene, we evaluated these AREs in their native context, a 6.5-kb AR genomic fragment. Androgen regulated the 6.5-kb AR genomic fragment and the 350-bp region of the AR cDNA at comparable levels, suggesting that sequences in exons D and E are likely to be involved in androgen-mediated up-regulation of the native AR gene. Furthermore, androgen regulated both responsive regions in U2OS cells, a human osteoblastic cell line that exhibits androgen-mediated up-regulation of native AR mRNA. DNAse I footprinting of the 350-bp region with recombinant AR (DNA- and ligand-binding domains) suggested the presence of additional AREs. Gel shift analyses and mutational studies showed that maximal androgen regulation and AR binding were dependent on the integrity of four AREs (ARE-1, ARE-1A, IVSARE, and ARE-2). While the presence of multiple, nonconsensus AREs is common among other androgen-regulated enhancers, the androgen-responsive region of the AR gene is unique because it contains exonic AREs. DNA binding studies with nuclear extracts were performed to determine whether non-AR transcription factors contribute to androgen regulation of the 350-bp region. These studies, in conjunction with mutational analysis and reporter gene assays with dominant negative Myc and Max expression vectors, showed that Myc and Max interaction with a Myc consensus site is required for androgen regulation of the 350-bp fragment. These results represent a novel interaction between AR and the Myc family of proteins and support a model of androgenic control of AR mRNA via AR and Myc family interaction with a unique internal androgen-responsive region harboring multiple exonic regulatory sequences.




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
S. Ko, L. Shi, S. Kim, C. S. Song, and B. Chatterjee
Interplay of Nuclear Factor-{kappa}B and B-myb in the Negative Regulation of Androgen Receptor Expression by Tumor Necrosis Factor {alpha}
Mol. Endocrinol., February 1, 2008; 22(2): 273 - 286.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
X. Ye, S. J. Han, S. Y. Tsai, F. J. DeMayo, J. Xu, M.-J. Tsai, and B. W. O'Malley
Roles of steroid receptor coactivator (SRC)-1 and transcriptional intermediary factor (TIF) 2 in androgen receptor activity in mice
PNAS, July 5, 2005; 102(27): 9487 - 9492.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
W. H Walker and J. Cheng
FSH and testosterone signaling in Sertoli cells
Reproduction, July 1, 2005; 130(1): 15 - 28.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. Sandelin and W. W. Wasserman
Prediction of Nuclear Hormone Receptor Response Elements
Mol. Endocrinol., March 1, 2005; 19(3): 595 - 606.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S.-T. Chiu, F.-J. Hsieh, S.-W. Chen, C.-L. Chen, H.-F. Shu, and H. Li
Clinicopathologic Correlation of Up-regulated Genes Identified Using cDNA Microarray and Real-time Reverse Transcription-PCR in Human Colorectal Cancer
Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 437 - 443.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Edwards, N. S. Krishna, C. J. Witton, and J. M. S. Bartlett
Gene Amplifications Associated with the Development of Hormone-Resistant Prostate Cancer
Clin. Cancer Res., November 1, 2003; 9(14): 5271 - 5281.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
P. L. Iversen, V. Arora, A. Acker, D. H. Mason, and G. R. Devi
Efficacy of Antisense Morpholino Oligomer Targeted to c-myc in Prostate Cancer Xenograft Murine Model and a Phase I Safety Study in Humans
Clin. Cancer Res., July 1, 2003; 9(7): 2510 - 2519.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
D. C. Mitchell and N. H. Ing
Estradiol Stabilizes Estrogen Receptor Messenger Ribonucleic Acid in Sheep Endometrium via Discrete Sequence Elements in Its 3'-Untranslated Region
Mol. Endocrinol., April 1, 2003; 17(4): 562 - 574.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
C. K. Cheng, C. H. Cheung, and W. M. Lee
Mouse Testin: Complementary DNA Cloning, Genomic Organization, and Characterization of Its Proximal Promoter Region
Biol Reprod, April 1, 2003; 68(4): 1376 - 1386.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Wu and D. M. Terrian
Regulation of Caveolin-1 Expression and Secretion by a Protein Kinase Cepsilon Signaling Pathway in Human Prostate Cancer Cells
J. Biol. Chem., October 18, 2002; 277(43): 40449 - 40455.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. D. Martinez and M. Danielsen
Loss of Androgen Receptor Transcriptional Activity at the G1/S Transition
J. Biol. Chem., August 9, 2002; 277(33): 29719 - 29729.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
E. P. Gelmann
Molecular Biology of the Androgen Receptor
J. Clin. Oncol., July 1, 2002; 20(13): 3001 - 3015.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
S. Ohsako, Y. Miyabara, M. Sakaue, R. Ishimura, M. Kakeyama, H. Izumi, J. Yonemoto, and C. Tohyama
Developmental Stage-Specific Effects of Perinatal 2,3,7,8-Tetrachlorodibenzo-p-dioxin Exposure on Reproductive Organs of Male Rat Offspring
Toxicol. Sci., April 1, 2002; 66(2): 283 - 292.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
H. Ostrer
Genome and Hormones: Gender Differences in Physiology: Invited Review: Sex-based differences in gene expression
J Appl Physiol, November 1, 2001; 91(5): 2384 - 2388.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
I. Bieche, B. Parfait, S. Tozlu, R. Lidereau, and M. Vidaud
Quantitation of androgen receptor gene expression in sporadic breast tumors by real-time RT-PCR: evidence that MYC is an AR-regulated gene
Carcinogenesis, September 1, 2001; 22(9): 1521 - 1526.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D.-L. Lin, M. C. Whitney, Z. Yao, and E. T. Keller
Interleukin-6 Induces Androgen Responsiveness in Prostate Cancer Cells through Up-Regulation of Androgen Receptor Expression
Clin. Cancer Res., June 1, 2001; 7(6): 1773 - 1781.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. M. Grad, L. S. Lyons, D. M. Robins, and K. L. Burnstein
The Androgen Receptor (AR) Amino-Terminus Imposes Androgen-Specific Regulation of AR Gene Expression via an Exonic Enhancer
Endocrinology, March 1, 2001; 142(3): 1107 - 1116.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
S. Ohsako, Y. Miyabara, N. Nishimura, S. Kurosawa, M. Sakaue, R. Ishimura, M. Sato, K. Takeda, Y. Aoki, H. Sone, et al.
Maternal Exposure to a Low Dose of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Suppressed the Development of Reproductive Organs of Male Rats: Dose-Dependent Increase of mRNA Levels of 5{{alpha}}-Reductase Type 2 in Contrast to Decrease of Androgen Receptor in the Pubertal Ventral Prostate
Toxicol. Sci., March 1, 2001; 60(1): 132 - 143.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. J. Reid, S. C. Hendy, J. Saito, P. Sorensen, and C. C. Nelson
Two Classes of Androgen Receptor Elements Mediate Cooperativity through Allosteric Interactions
J. Biol. Chem., January 19, 2001; 276(4): 2943 - 2952.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. D. Urnov and A. P. Wolffe
An Array of Positioned Nucleosomes Potentiates Thyroid Hormone Receptor Action in Vivo
J. Biol. Chem., June 1, 2001; 276(23): 19753 - 19761.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society